Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Amerifit enters continuing ed

This article was originally published in The Tan Sheet

Executive Summary

Amerifit Nutrition announces Feb. 1 it has provided its first unrestricted educational grant, totaling $120,000 for the development of a continuing education course for pharmacists. The Bloomfield, Conn.-based OTC marketing and distribution firm says the first CE course developed from the grant will focus on probiotics and antibiotic-associated diarrhea. "We are pleased to support continuing education for our pharmacist partners and to help advance the scientific data regarding probiotics because there are clear health benefits to consumers," Amerifit Nurition CEO Cyrill Siewert says in a press release...

You may also be interested in...

Execs On The Move: Major Changes At Foundation Medicine, Bardy And Lantheus

Genomic profiling firm Foundation Medicine hires new chief commercial officer; Bardy Diagnostics, developer of cardiac arrhythmia devices, picks a chief operating officer; Lantheus Medical Imaging, producer of diagnostic imaging agents and products; brings aboard a new chief medical officer; and more.

Coronavirus: Can Companies Achieve Vaccine Ambition?

Brilinta Boost For AZ In Stroke Study





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts